Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human TrkB ELISA Kit (AC2504)
Cat.#: ASET-1093
Specifications
Description Human TrkB ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human TrkB concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.13 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 3-48 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1990 Human CysLT2 ELISA Kit (AC3401) Quantitative inquiry ASET-1839 Human Chordin ELISA Kit (AC3250) Quantitative inquiry ASET-2258 Human CBLN2 ELISA Kit (AC3669) Quantitative inquiry ASET-1584 Human Semaphorin 7a ELISA Kit (AC2995) Quantitative inquiry ASET-2232 Rat GCLM ELISA Kit (AC3643) Quantitative inquiry ASET-1110 Mouse ABCA1 ELISA Kit (AC2521) Quantitative inquiry ASET-1297 Rat Myelin Basic Protein ELISA Kit (AC2708) Quantitative inquiry ASET-1026 Human Cadherin 8 ELISA Kit (AC2437) Quantitative inquiry ASET-1270 Mouse Asph ELISA Kit (AC2681) Quantitative inquiry ASET-1921 Mouse Semaphorin 3c ELISA Kit (AC3332) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket